Zepbound | search
Click here to view Zepbound news from 60+ newspapers.
Bookmark or Share- FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight ...INDIANAPOLIS, Nov. 8, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.
- FDA Approves New Medication for Chronic Weight ManagementToday, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/...
- Tirzepatide - WikipediaTirzepatide, sold under the brand names Mounjaro and Zepbound, is an antidiabetic medication used for the treatment of type 2 diabetes [10] [13] [14] [15] and for weight loss. [11] [16] Tirzepatide is administered via subcutaneous injections (under the skin). [10] [13]
- Zepbound (tirzepatide) Injection for Adults with Obesity or Excess WeightWhat is Zepbound? Zepbound is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off. Zepbound should be used with a reduced-calorie diet and increased physical activity.
- FDA approves Zepbound, new Wegovy rival : Shots - Health News : NPRDarron Cummings/AP. An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy....
More
